Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that have been associated with cardiovascular risk factors including elevated body weight and hypercholesterolemia. Therefore, PFAS may contribute to the development of atherosclerosis and cardiovascular disease (CVD). However, no previous study has evaluated associations between PFAS exposure and arterial calcification. METHODS AND RESULTS: This study used data from 666 prediabetic adults enrolled in the Diabetes Prevention Program trial who had six PFAS quantified in plasma at baseline and two years after randomization, as well as measurements of coronary artery calcium (CAC) and ascending (AsAC) and descending (DAC) thoracic aortic calcification 13-14 years after baseline. We performed multinomial regression to test associations between PFAS and CAC categorized according to Agatston score [low (<10), moderate (11-400) and severe (>400)]. We used logistic regression to assess associations between PFAS and presence of AsAC and DAC. We adjusted models for baseline sex, age, BMI, race/ethnicity, cigarette smoking, education, treatment assignment (placebo or lifestyle intervention), and statin use. PFAS concentrations were similar to national means; 53.9% of participants had CAC > 11, 7.7% had AsAC, and 42.6% had DAC. Each doubling of the mean sum of plasma concentrations of linear and branched isomers of perfluorooctane sulfonic acid (PFOS) was associated with 1.49-fold greater odds (95% CI: 1.01, 2.21) of severe versus low CAC. This association was driven mainly by the linear (n-PFOS) isomer [1.54 (95% CI: 1.05, 2.25) greater odds of severe versus low CAC]. Each doubling of mean plasma N-ethyl-perfluorooctane sulfonamido acetic acid concentration was associated with greater odds of CAC in a dose-dependent manner [OR = 1.26 (95% CI:1.08, 1.47) for moderate CAC and OR = 1.37 (95% CI:1.07, 1.74) for severe CAC, compared to low CAC)]. Mean plasma PFOS and n-PFOS were also associated with greater odds of AsAC [OR = 1.67 (95% CI:1.10, 2.54) and OR = 1.70 (95% CI:1.13, 2.56), respectively], but not DAC. Other PFAS were not associated with outcomes. CONCLUSIONS: Prediabetic adults with higher plasma concentrations of select PFAS had higher risk of coronary and thoracic aorta calcification. PFAS exposure may be a risk factor for adverse cardiovascular health among high-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Inclusion criteria were age ≥ 25 years, body mass index (BMI) ≥ 24 kg/m2 (≥22 kg/m2 in Asian Americans), fasting plasma glucose levels between 95 and 125 mg/ dL, and impaired glucose tolerance (2-hours after oral glucose load of 140–199 mg/dL) (Knowler et al., 2002).”
BackgroundCoronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., Liu, K., Shea, S., Szklo, M., Bluemke, D. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072100 · Cited by 2,989 · cited 1×
“CAC burden has been strongly and independently associated with increased incidence of CHD and CVD events beyond traditional risk factors (Detrano et al., 2008; Gibson et al., 2014), and it is part of American Heart Association and American College of Cardiology clinical cardiovascular risk guidelines (Dzaye et al.”
BackgroundPolyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628 · cited 1×
“Per- and polyfluoroalkyl substances (PFAS) are synthetic compounds commonly used in commercial applications and consumer products, such as stain-resistant and nonstick coatings, food packaging, and fire-fighting foams (Lindstrom et al., 2011).”
BackgroundHu, X. C., Andrews, D. Q., Lindstrom, A. B., Bruton, T. A., Schaider, L. A., Grandjean, P., Lohmann, R., Carignan, C. C., Blum, A., Balan, S. A., et al. (2016) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6b00260 · Cited by 1,333 · cited 2×
“, 2013), and contaminated drinking water (Hu et al., 2016; Hu et al., 2019).”
Background(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Trends in Exposure to Polyfluoroalkyl Chemicals in the U.S. Population: 1999−2008
Kato, K., Wong, L.-Y., Jia, L. T., Kuklenyik, Z., & Calafat, A. M. (2011) · Environmental Science & Technology · doi:10.1021/es1043613 · Cited by 777 · cited 7×
“We quantified PFAS in the plasma using solid-phase extraction followed by high-performance liquid chromatography coupled to isotope dilution-tandem mass spectrometry at the CDC (Kato et al., 2011).”
MethodInfluentialSelf-citation(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Kronmal, R. A., McClelland, R. L., Detrano, R., Shea, S., Lima, J. A., Cushman, M., Bild, D. E., & Burke, G. L. (2007) · Circulation · doi:10.1161/circulationaha.106.674143 · Cited by 560
Takacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396 · cited 1×
“The activation of PPAR-gamma was observed in one cell line study (Xu et al., 2016) but not in others (Wen et al., 2016; Takacs and Abbott, 2007).”
BackgroundFrisbee, S. J., Shankar, A., Knox, S. S., Steenland, K., Savitz, D. A., Fletcher, T., & Ducatman, A. M. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.163 · Cited by 274 · cited 1×
“Moreover, PFOS concentrations have been associated with higher lipid levels (Frisbee et al., 2010; Steenland et al., 2009), uric acid increase (Steenland et al.”
BackgroundSteenland, K., Tinker, S., Shankar, A., & Ducatman, A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0900940 · Cited by 224 · cited 1×
“, 2009), uric acid increase (Steenland et al., 2010) and insulin resistance (Cardenas et al.”
BackgroundQian, Y., Ducatman, A., Ward, R., Leonard, S., Bukowski, V., Lan Guo, N., Shi, X., Vallyathan, V., & Castranova, V. (2010) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287391003689317 · Cited by 191
Cited by
Perfluoroalkyl/polyfluoroalkyl substances: Links to cardiovascular disease risk
Schlezinger, J. J., & Gokce, N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323697 · Cited by 103
Li, H., Chen, J., Lu, J., Yang, J., Tan, Z., Li, L., Xiao, F., An, Z., Ma, C., Liu, Y., et al. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2022.137464 · Cited by 35
Yang, M., Su, W., Li, H., Li, L., An, Z., Xiao, F., Liu, Y., Zhang, X., Liu, X., Guo, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115473 · Cited by 23
Endocrine-disrupting chemicals exposure: Cardiometabolic health risk in humans
Ma, C.-X., Ma, X.-N., Li, H.-L., Mauricio, D., & Fu, S.-B. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02938-8 · Cited by 19
“Regarding the role of EDCs in atherogenesis, a study using data from the Diabetes Prevention Program trial in the USA showed a positive association of higher plasma concentrations of PFAS and an increased risk of coronary and thoracic aorta calcification in predia-betic adults [176].”
Yang, J., Wang, T., Li, K., & Wāng, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.022 · Cited by 15
Metadata
- Authors
- Osorio-Yáñez, C., Sanchez-Guerra, M., Cardenas, A., Lin, P.-I. D., Hauser, R., Gold, D. R., Kleinman, K. P., Hivert, M.-F., Fleisch, A. F., Calafat, A. M., Webster, T. F., Horton, E. S., & Oken, E.
- Venue
- Environment International
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 151
- Pages
- 106446
- ISSN
- 0160-4120 (ISSN-L)
- OpenAlex
- W3129376062
- Cited by
- 36
- References
- 12
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.